Patrick Waters
BSc PhD CSci FIBMS FRCPath
Co-Director Autoimmune Neurology Diagnostic Laboratory
CNS autoimmunity, Assay development, Antibody cloning
My research focuses on antibody mediated central nervous system diseases. I am interested in the discovery of new antibody targets, the optimisation of assays to detect antibodies in patients serum and CSF, and understanding the mechanism through which the antibodies cause disease.
Research groups
Recent publications
-
Frequency of MOG-IgG in cerebrospinal fluid versus serum
Journal article
Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry
-
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
Journal article
McGinty RN. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry, 92, 291 - 294
-
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Journal article
Cross H. et al, (2021), Frontiers in Neurology, 11
-
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Journal article
Michael S. et al, (2020), Practical Neurology, 20, 377 - 384
-
Prevalence of NMOSD and MS in the Indigenous Populations of Australia and New Zealand
Conference paper
Broadley SA. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP44 - NP44